skin cancer Archive
-
October 25, 2012
Combined drug therapy may delay melanoma progression
Combination therapy with two drugs delayed the development of treatment resistance in patients with metastatic melanoma that expresses a specific mutation in the BRAF gene. -
July 26, 2012
Study finds mutation in melanoma sensitive to drug
An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation. -
April 26, 2012
New drug mutes more melanomas
An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies. -
January 26, 2012
Investigators seek clues to resistance to melanoma drug
Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug. -
January 5, 2012
Sosman named to ‘Dream Team’ of cancer investigators
-
December 15, 2011
Jeffrey Sosman named to melanoma research ‘Dream Team’
-
May 10, 2011
Free skin cancer screening May 21
Free skin cancer screenings will be offered at Vanderbilt Health One Hundred Oaks May 21 in conjunction with Skin Cancer Awareness month.